Edwards Lifesciences said Monday it exercised an option to buy Innovalve Bio Medical, an Israel-based startup that is developing transcatheter mitral valve replacement technologies. Edwards expects to ...

Edwards Lifesciences, a medical technology company based in the US, has announced the complete acquisition of Innovalve Bio Medical, which specialises in transcatheter heart valve devices. The ...

Edwards Lifesciences Corp. (NYSE: EW) today announced its plans to acquire Innovalve Bio Medical, an early stage transcatheter mitral valve replacement (TMVR) company, for about $300 million in cash.

(RTTNews) - Edwards Lifesciences (EW) said it has exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement company, following its initial investment ...

Edwards Lifesciences Corporation EW announced its decision to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company. This follows Edwards Lifescience ...

Edwards Lifesciences Corp. said it has exercised its option to buy Innovalve Bio Medical Ltd., an early stage transcatheter mitral valve replacemen company, for $300 million in cash following its ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve ...